Ambient Clinical Analytics Raises $5M, Appoints Brian Tufts as CEO

Ambient Clinical Analytics Raises $5M, Appoints Brian Tufts as CEO

HIT Consultant – Read More

What You Should Know

  • The Capital: Ambient Clinical Analytics has closed a $5M strategic funding round. Investors include Mairs & Power Venture Capital and an unnamed Fortune 500 MedTech firm.
  • The Leadership Shift: Brian Tufts, a veteran executive with experience at Vantive and Baxter, has been appointed as the new Chief Executive Officer. Founder Al Berning is transitioning to the role of Executive Chairman.
  • The Technology: The company’s flagship product is the AWARE™ platform, an FDA Class II-cleared system built on clinically validated algorithms and technology licensed from the Mayo Clinic.
  • The Clinical Focus: The platform delivers real-time clinical analytics and clinical decision support (CDS) across bedside care, command centers, and remote monitoring environments. A major use case is improving protocol adherence for sepsis care, a notoriously difficult and time-sensitive workflow.
  • The Goal: The new capital will be utilized to accelerate innovation, expand the platform’s adoption across health systems, and deepen strategic partnerships in high-acuity environments.

 

Chatbots are now prescribing psychiatric drugs

Chatbots are now prescribing psychiatric drugs

FDB Launches MedProof MCP to Ground AI Agents in Clinical Drug Knowledge

FDB Launches MedProof MCP to Ground AI Agents in Clinical Drug Knowledge